UBS OCONNOR LLC - LEXICON PHARMACEUTICALS INC ownership

LEXICON PHARMACEUTICALS INC's ticker is and the CUSIP is 528872AB0. A total of 9 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 1.1%.

Quarter-by-quarter ownership
UBS OCONNOR LLC ownership history of LEXICON PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$21,586,000,000
-20.4%
12,000,0000.0%0.42%
+3.5%
Q3 2016$27,118,000,000
+20.4%
12,000,0000.0%0.40%
-17.1%
Q2 2016$22,523,000,000
+64.2%
12,000,000
+41.2%
0.49%
+92.9%
Q1 2016$13,714,000,000
-8.3%
8,500,0000.0%0.25%0.0%
Q4 2015$14,952,000,0008,500,0000.25%
Other shareholders
LEXICON PHARMACEUTICALS INC shareholders Q3 2016
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 14,500,000$15,044,0001.87%
WOLVERINE ASSET MANAGEMENT LLC 12,250,000$12,530,0000.17%
DeepCurrents Investment Group LLC 1,000,000$1,107,0000.10%
Verition Fund Management LLC 709,000$716,0000.03%
LAZARD ASSET MANAGEMENT LLC 10,000,000$10,105,0000.02%
Citadel Advisors 31,800,000$32,140,0000.02%
UBS ASSET MANAGEMENT AMERICAS INC 10,500,000$10,735,200,0000.01%
DEUTSCHE BANK AG\ 4,500,000$4,525,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 2,500,000$2,513,0000.00%
MACKAY SHIELDS LLC 157,000$159,0000.00%
View complete list of LEXICON PHARMACEUTICALS INC shareholders